-
1
-
-
70449370231
-
Revised american thyroid association manage ment guidelines for patients with thyroid nodules and differentiated thyroid cancer
-
American Thyroid Association (ATA Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer
-
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association manage ment guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
-
(2009)
Thyroid
, vol.19
, pp. 1167-1214
-
-
Cooper, D.S.1
Doherty, G.M.2
Haugen, B.R.3
-
3
-
-
59649108225
-
Hürthle cell carcinoma of the thyroid: Ret rospective review of 62 patients treated at the royal marsden hospital between 1946 and 2003
-
Mills SC, Haq M, Smellie WJ, Harmer C. Hürthle cell carcinoma of the thyroid: ret rospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol. 2009; 35:230-234.
-
(2009)
Eur J Surg Oncol
, vol.35
, pp. 230-234
-
-
Mills, S.C.1
Haq, M.2
Smellie, W.J.3
Harmer, C.4
-
4
-
-
0030442842
-
Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid
-
Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg. 1996;172:692-694.
-
(1996)
Am J Surg
, vol.172
, pp. 692-694
-
-
Shaha, A.R.1
Shah, J.P.2
Loree, T.R.3
-
5
-
-
84863453704
-
Histological patterns of locoregional recurrence in hürthle cell carcinoma of the thyroid gland
-
Bishop JA, Wu G, Tufano RP, Westra WH. Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland. Thyroid. 2012;22:690-694.
-
(2012)
Thyroid
, vol.22
, pp. 690-694
-
-
Bishop, J.A.1
Wu, G.2
Tufano, R.P.3
Westra, W.H.4
-
6
-
-
40949154349
-
Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with hürthle cell or follicular thyroid cancer
-
Kushchayeva Y, Duh QY, Kebebew E, D'Avanzo A, Clark OH. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hürthle cell or follicular thyroid cancer. Am J Surg. 2008;195:457-462.
-
(2008)
Am J Surg
, vol.195
, pp. 457-462
-
-
Kushchayeva, Y.1
Duh, Q.Y.2
Kebebew, E.3
D'Avanzo, A.4
Clark, O.H.5
-
7
-
-
0032587215
-
Hürthle cell carcinoma: A malignancy of low-grade potential
-
Khafif A, Khafif RA, Attie JN. Hürthle cell carcinoma: a malignancy of low-grade potential. Head Neck. 1999;21:506-511.
-
(1999)
Head Neck
, vol.21
, pp. 506-511
-
-
Khafif, A.1
Khafif, R.A.2
Attie, J.N.3
-
8
-
-
0037319864
-
Survival and prognosis in hürthle cell carcinoma of the thyroid gland
-
Bhattacharyya N. Survival and prognosis in Hürthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg. 2003;129: 207-210.
-
(2003)
Arch Otolaryngol Head Neck Surg
, vol.129
, pp. 207-210
-
-
Bhattacharyya, N.1
-
9
-
-
29144508427
-
The treatment and prognosis of hürthle cell follicular thyroid carcinoma compared with its non-hürthle cell counterpart
-
discussion 1157-1158
-
Haigh PI, Urbach DR. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Surgery. 2005;138:1152-1157; discussion 1157-1158.
-
(2005)
Surgery
, vol.138
, pp. 1152-1157
-
-
Haigh, P.I.1
Urbach, D.R.2
-
10
-
-
84888010592
-
Hurthle cell carcinoma: An update on survival over the last 35 years
-
discussion 1271
-
Nagar S, Aschebrook-Kilfoy B, Kaplan EL, Angelos P, Grogan RH. Hurthle cell carcinoma: an update on survival over the last 35 years. Surgery. 2013;154:1263-1271; discussion 1271.
-
(2013)
Surgery
, vol.154
, pp. 1263-1271
-
-
Nagar, S.1
Aschebrook-Kilfoy, B.2
Kaplan, E.L.3
Angelos, P.4
Grogan, R.H.5
-
11
-
-
84872912002
-
Hürthle cell carcinoma: A population-level analysis of 3311 patients
-
Goffredo P, Roman SA, Sosa JA. Hürthle cell carcinoma: a population-level analysis of 3311 patients. Cancer. 2013;119:504-511.
-
(2013)
Cancer
, vol.119
, pp. 504-511
-
-
Goffredo, P.1
Roman, S.A.2
Sosa, J.A.3
-
12
-
-
84877710820
-
Genomic dissection of hürthle cell carcinoma reveals a unique class of thyroid malignancy
-
Ganly I, Ricarte Filho J, Eng S, et al. Genomic dissection of Hürthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab. 2013;98:E962-E972.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. E962-E972
-
-
Ganly, I.1
Ricarte Filho, J.2
Eng, S.3
-
14
-
-
64249099411
-
-
7th ed. New York NY Springer
-
Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer; 2010.
-
(2010)
AJCC Cancer Staging Manual
-
-
Edge, S.1
Byrd, D.R.2
Compton, C.C.3
Fritz, A.G.4
Greene, F.L.5
Trotti, A.6
-
15
-
-
84874191269
-
Tert promoter mutations in familial and sporadic melanoma
-
Horn S, Fi gl A, Rachakonda PS, et al. TERT promoter mutations in familial and sporadic melanoma. Science. 2013;339:959-961.
-
(2013)
Science
, vol.339
, pp. 959-961
-
-
Horn, S.1
Figl, A.2
Rachakonda, P.S.3
-
16
-
-
84883711485
-
Frequent somatic tert promote r mutations in thyroid cancer: Higher prevalence in advanced forms of the disease
-
Landa I, Ganly I, Chan TA, et al. Frequent somatic TERT promote r mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab. 2013;98:E1562-E1566.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. E1562-E1566
-
-
Landa, I.1
Ganly, I.2
Chan, T.A.3
-
17
-
-
84899908886
-
Tert promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
-
Melo M, da Rocha AG, Vinagre J, et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2014;99:E754-E765.
-
(2014)
J Clin Endocrinol Metab
, vol.99
, pp. E754-E765
-
-
Melo, M.1
Da Rocha, A.G.2
Vinagre, J.3
-
18
-
-
84908556575
-
Tert promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (fta) and atypical fta
-
Wang N, Liu T, Sofiadis A, et al. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. Cancer 2014;120:2965-2979.
-
(2014)
Cancer
, vol.120
, pp. 2965-2979
-
-
Wang, N.1
Liu, T.2
Sofiadis, A.3
-
20
-
-
16644373943
-
Prognostic indications for hürthle cell cancer
-
Kushchayeva Y,Duh QY,Kebebew E,Clark OH Prognostic indications for Hürthle cell cancer World J Surg. 2004 28, 1266-1270.
-
(2004)
World J Surg
, vol.28
, pp. 1266-1270
-
-
Kushchayeva, Y.1
Duh, Q.Y.2
Kebebew, E.3
Clark, O.H.4
-
21
-
-
0037369140
-
Prognostic factors in patients with hürthle cell neoplasms of the thyroid
-
Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer. 2003; 97:1186-1194.
-
(2003)
Cancer
, vol.97
, pp. 1186-1194
-
-
Lopez-Penabad, L.1
Chiu, A.C.2
Hoff, A.O.3
-
22
-
-
0035873951
-
Hürthle cell carcinoma: A critical histopathologic appraisal
-
Stojadinovic A, Ghossein RA, Hoos A, et al. Hürthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol. 2001;19:2616-2625.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2616-2625
-
-
Stojadinovic, A.1
Ghossein, R.A.2
Hoos, A.3
-
23
-
-
33646056429
-
Prognostic factors of recurrence in encapsulated hürthle cell carcinoma of the thyroid gland: A clinicopathologic study of 50 cases
-
Ghossein RA, Hiltzik DH, Carlson DL, et al. Prognostic factors of recurrence in encapsulated Hürthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer. 2006;106 : 1669-1676.
-
(2006)
Cancer
, vol.106
, pp. 1669-1676
-
-
Ghossein, R.A.1
Hiltzik, D.H.2
Carlson, D.L.3
-
24
-
-
0033952494
-
Metastatic minimally invasive (encapsulated) follicular and hürthle cell thyroid carcinoma: A study of 34 patients
-
Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hürthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol. 2000;13:123-13 0.
-
(2000)
Mod Pathol
, vol.13
, pp. 123-130
-
-
Goldstein, N.S.1
Czako, P.2
Neill, J.S.3
-
25
-
-
33744535887
-
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer
-
Lind P, Kohlfürst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med. 2006;36:194-205.
-
(2006)
Semin Nucl Med
, vol.36
, pp. 194-205
-
-
Lind, P.1
Kohlfürst, S.2
-
26
-
-
79251482826
-
Thyroid cancer-indications and opportunities for positron emission tomography/computed tomography imaging
-
Abraham T, Schöder H. Thyroid cancer-indications and opportunities for positron emission tomography/computed tomography imaging. Semin Nucl Med. 2011;41:121-138.
-
(2011)
Semin Nucl Med
, vol.41
, pp. 121-138
-
-
Abraham, T.1
Schöder, H.2
-
27
-
-
0022627413
-
Hürthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy
-
Har-El G, Hadar T, Segal K, Levy R, Sidi J. Hürthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer. 1986;57:1613-1617.
-
(1986)
Cancer
, vol.57
, pp. 1613-1617
-
-
Har-El, G.1
Hadar, T.2
Segal, K.3
Levy, R.4
Sidi, J.5
-
28
-
-
84864711852
-
Postradioio dine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels
-
Leboulleux S, El Bez I, Borget I, et al. Postradioio dine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels. Thyroid. 2012;22:832-838.
-
(2012)
Thyroid
, vol.22
, pp. 832-838
-
-
Leboulleux, S.1
El Bez, I.2
Borget, I.3
-
29
-
-
84872349927
-
The role of 18f-fluorodeoxyglucose positron emission tomography in the prognostication, diagnosis, and management of thyroid carcinoma
-
Lang B H. The role of 18F-fluorodeoxyglucose positron emission tomography in the prognostication, diagnosis, and management of thyroid carcinoma. J Thyroid Res. 2012;2012:198313.
-
(2012)
J Thyroid Res
, vol.2012
, pp. 198313
-
-
Lang, B.H.1
-
30
-
-
33749046302
-
Diagnostic accuracy and prognostic value of 18f-fdg pet in hürthle cell thyroid cancer patients
-
Pryma DA, Schöder H, Gönen M, Robbins RJ, Larson SM, Yeung HW. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients. J Nucl Med. 2006;47:1260-1266.
-
(2006)
J Nucl Med
, vol.47
, pp. 1260-1266
-
-
Pryma, D.A.1
Schöder, H.2
Gönen, M.3
Robbins, R.J.4
Larson, S.M.5
Yeung, H.W.6
-
31
-
-
84883711485
-
Frequent somatic tert promoter mutations in thyroid cancer: Higher prevalence in advanced forms of the disease
-
Landa I, Ganly I, Chan TA, Mitsutake N, Matsuse M, Ibrahimpasic T, Ghossein RA, Fagin JA. Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab. 2013;98:E1562-E1566.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. E1562-E1566
-
-
Landa, I.1
Ganly, I.2
Chan, T.A.3
Mitsutake, N.4
Matsuse, M.5
Ibrahimpasic, T.6
Ghossein, R.A.7
Fagin, J.A.8
|